Home › Funds › Headland Capital, LLC › BSX

Headland Capital, LLC position in BSX

Boston Scientific Corp · Health Care

Headland Capital, LLC reported holding 62,652 shares of BSX (Boston Scientific Corp) in its Q3 2026 13F filing — a position valued at US$2.7M, representing 0.68% of its reported portfolio and ranking #20 among its reported holdings. Headland Capital, LLC has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)62.65K sh
Reported value held$2.73M
Portfolio Weight0.68%
First reportedQ4 2024
Last changeReduce
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How Headland Capital, LLC's BSX position evolved

Headland Capital, LLC first disclosed a stake in BSX in Q4 2024 at 88,886 shares (US$7.9M). The position peaked in Q2 2025 at 89,704 shares, worth US$9.6M. Across 8 filings, Headland Capital, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 62,652 shares valued at US$2.7M — a reduction of -42,461 shares quarter over quarter.. Notable position changes include a 40% trim in Q3 2026 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 88.89K $7.94M New
Q1 2025 88.26K $8.90M Reduce
Q2 2025 89.70K $9.64M Add
Q3 2025 90.64K $8.85M Add
Q4 2025 90.51K $8.63M Hold
Q1 2026 94.26K $5.91M Add
Q2 2026 105.11K $4.49M Add
Q3 2026 62.65K $2.73M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About BSX and 13F data

BSX (Boston Scientific Corp) is a Health Care company. 20 other funds we track also report a position in BSX — the largest reported positions include Banque Cantonale Vaudoise (US$2.89B), PRIMECAP MANAGEMENT CO/CA/ (US$2.16B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding BSX

All BSX fund holders →

FAQ

How long has Headland Capital, LLC held BSX?

Headland Capital, LLC has disclosed BSX holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Headland Capital, LLC's current position in BSX?

As of Q3 2026, Headland Capital, LLC holds 62.65K shares of BSX (Boston Scientific Corp), valued at $2.73M, representing 0.68% of its reported portfolio and ranking #20.

Has Headland Capital, LLC been buying or selling BSX?

In the latest 13F filing (Q3 2026), Headland Capital, LLC reduced its position in BSX. The position peaked in Q2 2025 at 89.70K shares.

Which other funds hold BSX?

Other major institutional holders of BSX include Banque Cantonale Vaudoise, PRIMECAP MANAGEMENT CO/CA/, D. E. Shaw & Co, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.